The Genesis Conference, which is organised by the ONE NUCLEUS cluster (London and Cambridge), and, this year, celebrates its tenth anniversary, is a key event in the life-sciences sector. For the fifth consecutive year, Genesis will give five innovative French companies the opportunity to showcase their services and expertise, thanks to the support provided by the French Trade Commission UBIFRANCE in London.
The companies taking part in the French Pavilion are as follows. Further details can be provided on request.
Founded in 1993, ALCIMED assists decision-makers in terms of their strategic development and their positioning. ALCIMED acts as the interface between science and business, and helps clients – be they sales and marketing directors, corporate-level directors, or R&D managers – to grasp new opportunities, adapt to potential threats such as changes in regulation, come up with novel solutions, and translate ideas into practice.
ALCIMED employs 180 highly skilled people across four countries and will open its London office in 2012.
For more information, please go to: www.alcimed.com
Aureus Pharma provides a range of scientific knowledge solutions enabling biopharmaceutical companies to better understand the chemical and biological space around major therapeutic targets and, therefore, to better identify drug profiles. Aureus Pharma’s information solutions streamline the discovery process for many of the world’s most successful biopharmaceutical companies and leading research institutions.
The new Aureus Sciences Web Portal will be released in 2011, which will allow professionals in the pharmaceutical and biotech sectors to access a collaborative network, as well as editorial content, and specific dashboards.
For more information, please go to: www.aureus-pharma.com
Bertin Pharma offers a comprehensive and integrated range of products and services throughout the drug-development value chain. The company was created out of a merger between four well-established French companies – Biotec Centre, Ellipse Pharmaceuticals, IDPS and SPI-Bio. Bertin Pharma now employs over 100 pharmacists, scientists and technicians.
Bertin Pharma positions itself as “an ideal partner for preclinical, clinical and pharmaceutical development, as well as bio-safety studies”. The company offers expertise, innovative technologies, dedicated technical platforms, environments with appropriate quality standards (GLP, GMP and GDP) and specific competencies applied to biologics.
For more information, please go to: www.bertin.fr
HISTALIM is a technical platform for histology, cytology and molecular biology, offering a large range of services addressing the pharmaceutical and CRO sectors.
HISTALIM is now embarking on its next stage of development, in the hope of becoming the reference platform for histology, cytology and molecular biology for every application type within the next five years. Its goal is also to become a key partner for method-designing and image-analysis applications in histotechnology.
For more information, please go to: www.histalim.com
Keyrus Biopharma is a European CRO offering a complete range of services from preclinical to post-marketing studies. Keyrus Biopharma divides its expertise into five main areas: clinical operations, biometry, medical writing, pharmacovigilance and quality assurance. With over 12 years’ experience in clinical trials, Keyrus Biopharma has worked with a number of major clients in the fields of medicine, nutrition, vaccines, biotechnology, medical devices and cosmetics.
A rapidly expanding company, Keyrus Biopharma plans to invest in the British market in the next two years in order to meet the demand of its clients.
For more information, please go to: www.keyrusbiopharma.com
About the French Trade Commission UBIFRANCE
The Trade Commission of the French Embassy in London promotes trade development between France and the UK by offering a range of services to French-based companies. The Consumer Goods and Healthcare Department organises B2B events in the form of conferences and networking opportunities, mainly in London.
Genesis will take place at the QEII Conference Centre in central London (England) on 9 December 2010. It will bring together professionals from across the biotechnology and life-sciences sectors.
For more information, please contact Ms Judith Arkle, Senior Trade Adviser in charge of healthcare and biotechnology at the French Trade Commission UBIFRANCE in London, or Ms Mary-Ann Williams, Press Officer.Ms Judith Arkle
Mary-Ann Williams | UBIFRANCE
Fraunhofer ISE with over 60 Contributions at the European PV Solar Energy Conference and Exhibition
21.09.2018 | Fraunhofer-Institut für Solare Energiesysteme ISE
IAA Commercial Vehicles 2018: Commercial vehicle model autonomously explores its surroundings
10.09.2018 | Technische Universität Kaiserslautern
The building blocks of matter in our universe were formed in the first 10 microseconds of its existence, according to the currently accepted scientific picture. After the Big Bang about 13.7 billion years ago, matter consisted mainly of quarks and gluons, two types of elementary particles whose interactions are governed by quantum chromodynamics (QCD), the theory of strong interaction. In the early universe, these particles moved (nearly) freely in a quark-gluon plasma.
This is a joint press release of University Muenster and Heidelberg as well as the GSI Helmholtzzentrum für Schwerionenforschung in Darmstadt.
Then, in a phase transition, they combined and formed hadrons, among them the building blocks of atomic nuclei, protons and neutrons. In the current issue of...
Thin-film solar cells made of crystalline silicon are inexpensive and achieve efficiencies of a good 14 percent. However, they could do even better if their shiny surfaces reflected less light. A team led by Prof. Christiane Becker from the Helmholtz-Zentrum Berlin (HZB) has now patented a sophisticated new solution to this problem.
"It is not enough simply to bring more light into the cell," says Christiane Becker. Such surface structures can even ultimately reduce the efficiency by...
A study in the journal Bulletin of Marine Science describes a new, blood-red species of octocoral found in Panama. The species in the genus Thesea was discovered in the threatened low-light reef environment on Hannibal Bank, 60 kilometers off mainland Pacific Panama, by researchers at the Smithsonian Tropical Research Institute in Panama (STRI) and the Centro de Investigación en Ciencias del Mar y Limnología (CIMAR) at the University of Costa Rica.
Scientists established the new species, Thesea dalioi, by comparing its physical traits, such as branch thickness and the bright red colony color, with the...
Scientists have succeeded in observing the first long-distance transfer of information in a magnetic group of materials known as antiferromagnets.
An international team of researchers has mapped Nemo's genome, providing the research community with an invaluable resource to decode the response of fish to...
21.09.2018 | Event News
03.09.2018 | Event News
27.08.2018 | Event News
21.09.2018 | Physics and Astronomy
21.09.2018 | Life Sciences
21.09.2018 | Event News